SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-105561"
 

Search: onr:"swepub:oai:DiVA.org:uu-105561" > Quantitative real-t...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome

Bergqvist, Jenny (author)
Karolinska Institutet
Ohd, J. F. (author)
Smeds, J. (author)
Karolinska Institutet
show more...
Klaar, Sigrid (author)
Isola, J. (author)
Nordgren, Hans (author)
Uppsala universitet,Institutionen för patologi
Elmberger, G. P. (author)
Hellborg, H. (author)
Bjohle, J. (author)
Karolinska Institutet
Borg, A-L. (author)
Skoog, L. (author)
Karolinska Institutet
Bergh, J. (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
Elsevier BV, 2007
2007
English.
In: Annals of Oncology. - : Elsevier BV. - 0923-7534 .- 1569-8041. ; 18:5, s. 845-850
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND: Our aim was to use quantitative real-time PCR (Q-PCR) and RNA expression profiles (RNA-EPs) to investigate HER2 status in relation to outcome. PATIENTS AND METHODS: Cut-off levels for Q-PCR and RNA-EP were established in relation to immunohistochemistry (IHC) validated by FISH in a test set of frozen tissue samples from 40 primary breast cancers. The HER2 status was subsequently studied in another validation set of 306 tumors, where Q-PCR and RNA-EP results were compared with previously carried out IHC that we had validated by chromogenic in situ hybridization (CISH). RESULTS: Q-PCR and RNA-EP offered similar sensitivity (90% versus 77%), specificity (93% versus 95%), and negative (99% versus 98%) and positive (63% versus 61%) predictive values for HER2 determinations. Analyses of relapse-free survival (RFS) and overall survival on the basis of 5 and 10 years of follow-up indicated equivalent hazard ratios for all three techniques. In contrast to IHC/CISH, both Q-PCR and RNA-EP analyses of HER2 also gave statistically significant results regarding RFS and breast cancer-corrected survival after 10 years of follow-up. CONCLUSION: The use of RNA-EP and Q-PCR to analyze HER2 in frozen and formalin-fixed breast cancer samples may be an alternate approach to IHC in combination with FISH/CISH.

Keyword

breast cancer
CISH
diagnostic methods
HER2
quantitative real-time PCR
RNA expression profiles
MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view